Skip to content

Clinical study of adding lactoferrin three-stage milk powder to improve cellular immunity and humoral immunity

Clinical study of adding lactoferrin three-stage milk powder to improve cellular immunity and humoral immunity

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300074559
Enrollment
Unknown
Registered
2023-08-09
Start date
2022-11-26
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

immunity

Interventions

Control group:Common infant formula
Experimental group:Bovine lactoferrin supplementation of infant formula

Sponsors

Affiliated Hospital of Jiangnan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Months to 13 Months

Inclusion criteria

Inclusion criteria: Age 12 to 13 months ; physical health, and height and weight according to ' China growth and development of children under 7 reference standard ' are in the normal range.

Exclusion criteria

Exclusion criteria: Patients with severe milk protein allergy or family history ; patients with lactose intolerance or family history ; those whose height and weight development did not reach the standard ; severe, persistent or chronic diarrhea ; severe infection requiring hospitalization in the previous month ; severe chronic diseases ; with underlying diseases ( including but not limited to : pediatric kidney disease, hyperactivity and other mental illness, leukemia, etc. ).

Design outcomes

Primary

MeasureTime frame
intestinal flora;blood routine;immunoglobulin;calprotectin;secretory IgA;SCFAs;

Secondary

MeasureTime frame
Head circumference;Weight;Height;

Countries

China

Contacts

Public ContactHong Cao

Affiliated Hospital of Jiangnan University

violet_cao@163.com+86 530 151 6179

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026